Thursday, January 1, 2026

HD FLASH NEWS

Where Information Sparks Brilliance

HomeTop StoriesFDA approves new treatment to slow progression of early Alzheimer's

FDA approves new treatment to slow progression of early Alzheimer’s


FDA approves new treatment to slow progression of early Alzheimer’s – CBS News


Watch CBS News



The FDA approved a new Alzheimer’s treatment called donanemab on Tuesday. It is designed to help patients in the early stages of the disease. CBS News chief medical correspondent Dr. Jon LaPook explains what to know.

Be the first to know

Get browser notifications for breaking news, live events, and exclusive reporting.




Source link

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments